企業プロフィール
Biotricity 株価・ニュース・カタリスト
- ティッカー:
- BTCY
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.06 USD (-12.02%)
終値
最終更新: 2026年10月1日
—
時価総額
株価変動の要因
2026年10月1日 時点で BTCY は 12.0% 下落し、$0.0587 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Remote Cardiac Monitoring Company
Biotricity develops connected devices and software for cardiac diagnostics and chronic-care monitoring. Its platform links wearable sensors, cloud analytics, certified monitoring centers, and physician workflows.
Bioflux Mobile Cardiac Telemetry
Bioflux is a mobile cardiac telemetry system used to monitor patients for arrhythmias over extended periods. Data are transmitted to a monitoring center so clinically significant events can be reviewed and communicated to healthcare providers.
Biotres Extended Holter
Biotres is a wearable Holter device designed for multi-day recording and analysis. It broadens the company's diagnostic portfolio for physicians who need continuous rhythm data without full real-time telemetry.
Recurring Monitoring Economics
Biotricity generates revenue from devices, software, monitoring services, and reimbursable diagnostic tests. Growth depends on expanding the installed physician base and increasing the number of monitored patients per practice.
Consumer and Chronic-Care Products
Bioheart and related applications extend the technology into personal heart monitoring and longer-term disease management. The company is building a connected ecosystem that can support both prescribed diagnostics and ongoing patient engagement.
今後のカタリスト
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。